{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:27:15Z","timestamp":1793683635164,"version":"4.5.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007052","name":"MEMORIAL SLOAN KETTERING CANCER CENTER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.humpath.2026.106273","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:13:14Z","timestamp":1791501194000},"page":"106273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive genomic characterization of primary dermal melanoma: Delineating it from metastatic melanoma with unknown primary"],"prefix":"10.1016","author":[{"given":"Joyce M.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-1870","authenticated-orcid":false,"given":"Jason C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim A.","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-652X","authenticated-orcid":false,"given":"Konstantinos","family":"Linos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-4412","authenticated-orcid":false,"given":"Alexander N.","family":"Shoushtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Postow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus J.","family":"Busam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106273_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archderm.136.11.1397","article-title":"Solitary melanoma confined to the dermal and\/or subcutaneous tissue: evidence for revisiting the staging classification","volume":"136","author":"Bowen","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pathol.2022.11.006","article-title":"Metastatic melanoma and rare melanoma variants: a review","volume":"55","author":"Lowe","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106273_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archderm.140.1.99","article-title":"Primary dermal melanoma: a distinct subtype of melanoma","volume":"140","author":"Swetter","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.ejso.2020.04.043","article-title":"Primary dermal melanoma: clinical behaviour, prognosis and treatment","volume":"46","author":"Harris","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106273_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaad.2014.07.051","article-title":"Primary dermal melanoma: a unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: a clinical, histologic, and gene expression-profiling study","volume":"71","author":"Sidiropoulos","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1245\/s10434-008-0272-9","article-title":"Solitary dermal melanoma: beginning or end of the metastatic process?","volume":"16","author":"Lee","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106273_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/ans.13116","article-title":"Primary dermal melanoma: a West Australian cohort","volume":"85","author":"Teow","year":"2015","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.humpath.2026.106273_bib8","article-title":"Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning","volume":"16","author":"Yang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106273_bib9","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2026.106273_bib10","first-page":"341","article-title":"Malignant melanoma of unknown primary origin","volume":"117","author":"Dasgupta","year":"1963","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.humpath.2026.106273_bib11","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/s41379-020-0594-0","article-title":"Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma","volume":"33","author":"Yang","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106273_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3833","article-title":"Prevalence of UV mutational signatures among cutaneous primary tumors","volume":"5","author":"Mata","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.humpath.2026.106273_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jaad.2016.08.028","article-title":"Mutational profile of primary dermal melanoma: A case series","volume":"75","author":"Sun","year":"2016","journal-title":"J Am Acad Dermatology"},{"key":"10.1016\/j.humpath.2026.106273_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2026.106273_bib16","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.humpath.2026.106273_bib17","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106273_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2026.106273_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.humpath.2026.106273_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.285","article-title":"KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.humpath.2026.106273_bib21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jaad.2016.08.028","article-title":"Mutational profile of primary dermal melanoma: a case series","volume":"75","author":"Sun","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2020.09.002","article-title":"Lack of distinct molecular profile of primary dermal melanoma","volume":"106","author":"Shaigany","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106273_bib23","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.18632\/oncotarget.14109","article-title":"Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application","volume":"8","author":"Chae","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2026.106273_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1096\/fasebj.9.10.7542215","article-title":"Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction","volume":"9","author":"Friesel","year":"1995","journal-title":"FASEB J"},{"key":"10.1016\/j.humpath.2026.106273_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2026.106273_bib26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00006534-199911000-00001","article-title":"Molecular diagnosis of bilateral coronal synostosis","volume":"104","author":"Mulliken","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.humpath.2026.106273_bib27","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/sj.jid.5700772","article-title":"FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin","volume":"127","author":"Hafner","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0298-184","article-title":"A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma","volume":"18","author":"Knezevich","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(01)00528-3","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma","volume":"132","author":"Sandberg","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2026.106273_bib30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00000478-200007000-00005","article-title":"Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors","volume":"24","author":"Bourgeois","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106273_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2026.106273_bib32","first-page":"5046","article-title":"ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma","volume":"58","author":"Knezevich","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106273_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106273_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1746-1596-6-19","article-title":"Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia","volume":"6","author":"Kralik","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106273_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.28484","article-title":"ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer","volume":"120","author":"Leeman-Neill","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106273_bib36","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1172\/JCI69766","article-title":"Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers","volume":"123","author":"Ricarte-Filho","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.humpath.2026.106273_bib37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.2611","article-title":"Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10059-013-0061-6","article-title":"TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1","volume":"36","author":"Kim","year":"2013","journal-title":"Mol Cells"},{"key":"10.1016\/j.humpath.2026.106273_bib40","first-page":"811","article-title":"TrkC expression predicts favorable clinical outcome in invasive ductal carcinoma of breast independent of NT-3 expression","volume":"4","author":"Zhang","year":"2014","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.humpath.2026.106273_bib41","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1073\/pnas.1212333110","article-title":"Dependence receptor TrkC is a putative Colon cancer tumor suppressor","volume":"110","author":"Genevois","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106273_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003552","article-title":"NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer","volume":"9","author":"Luo","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib43","first-page":"1395","article-title":"ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene","volume":"14","author":"Yasuda","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2026.106273_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/jhep.2002.30420","article-title":"Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma","volume":"35","author":"Ninomiya","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2026.106273_bib45","doi-asserted-by":"crossref","first-page":"14422","DOI":"10.1074\/jbc.274.20.14422","article-title":"Myb-interacting protein, ATBF1, represses transcriptional activity of myb oncoprotein","volume":"274","author":"Kaspar","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2026.106273_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1528","article-title":"Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer","volume":"37","author":"Sun","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2026.106273_bib48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1158\/2159-8290.CD-21-0521","article-title":"PD-1 blockade in solid tumors with defects in polymerase epsilon","volume":"12","author":"Rousseau","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2026.106273_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13073-023-01234-y","article-title":"Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1","volume":"15","author":"Mur","year":"2023","journal-title":"Genome Med"},{"key":"10.1016\/j.humpath.2026.106273_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/his.13984","article-title":"Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase epsilon (POLE)","volume":"76","author":"Forgo","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106273_bib51","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2017.09.048","article-title":"Comprehensive analysis of hypermutation in human cancer","volume":"171","author":"Campbell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2026.106273_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.annonc.2024.03.009","article-title":"Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer","volume":"35","author":"Ambrosini","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2026.106273_bib53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13046-022-02422-1","article-title":"POLE\/POLD1 mutation and tumor immunotherapy","volume":"41","author":"Ma","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106273_bib54","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41588-022-01108-w","article-title":"Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity","volume":"54","author":"Ma","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib55","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106273_bib56","first-page":"4682","article-title":"Ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106273_bib57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106273_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.jid.5700490","article-title":"Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations","volume":"127","author":"Bauer","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib59","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/MCB.21.6.2144-2153.2001","article-title":"Dual inactivation of RB and p53 pathways in RAS-induced melanomas","volume":"21","author":"Bardeesy","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2026.106273_bib60","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1755-148X.2011.00873.x","article-title":"Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma","volume":"24","author":"Devitt","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.humpath.2026.106273_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/zeb.2009.0606","article-title":"Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish","volume":"6","author":"Dovey","year":"2009","journal-title":"Zebrafish"},{"key":"10.1016\/j.humpath.2026.106273_bib62","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1101\/gad.12.19.3008","article-title":"Premature senescence involving p53 and p16 is activated in response to constitutive MEK\/MAPK mitogenic signaling","volume":"12","author":"Lin","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2026.106273_bib63","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1242\/dev.106567","article-title":"The melanocyte lineage in development and disease","volume":"142","author":"Mort","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.humpath.2026.106273_bib64","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s00018-013-1324-2","article-title":"Molecular and cellular pathogenesis of melanoma initiation and progression","volume":"70","author":"Regad","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2026.106273_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144852","article-title":"WNT signaling in Melanoma","volume":"21","author":"Gajos-Michniewicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2026.106273_bib66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2741\/1831","article-title":"The WNT\/Beta-catenin pathway in melanoma","volume":"11","author":"Larue","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.humpath.2026.106273_bib67","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/onc.2011.162","article-title":"In melanoma, beta-catenin is a suppressor of invasion","volume":"30","author":"Arozarena","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2026.106273_bib68","doi-asserted-by":"crossref","first-page":"43295","DOI":"10.18632\/oncotarget.9232","article-title":"The role of Wnt\/beta-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines","volume":"7","author":"Kovacs","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2026.106273_bib69","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-2133.2001.04336.x","article-title":"Loss of beta-catenin expression associated with disease progression in malignant melanoma","volume":"145","author":"Kageshita","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humpath.2026.106273_bib70","first-page":"3383","article-title":"Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma","volume":"9","author":"Maelandsmo","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106273_bib71","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ccr.2011.10.030","article-title":"beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas","volume":"20","author":"Damsky","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2026.106273_bib72","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/onc.2012.229","article-title":"Beta-catenin inhibits melanocyte migration but induces melanoma metastasis","volume":"32","author":"Gallagher","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2026.106273_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-018-0773-5","article-title":"Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype","volume":"17","author":"Sinnberg","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.humpath.2026.106273_bib74","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","article-title":"Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model","volume":"106","author":"Chien","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106273_bib75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.patbio.2008.11.003","article-title":"Bypassing melanocyte senescence by beta-catenin: a novel way to promote melanoma","volume":"57","author":"Larue","year":"2009","journal-title":"Pathol Biol"},{"key":"10.1016\/j.humpath.2026.106273_bib76","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1101\/gad.450107","article-title":"Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development","volume":"21","author":"Delmas","year":"2007","journal-title":"Genes Dev"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:46:09Z","timestamp":1793681169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772600242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":76,"alternative-id":["S004681772600242X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106273","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive genomic characterization of primary dermal melanoma: Delineating it from metastatic melanoma with unknown primary","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106273"}}